Sterile Antifungal Solution for Critical Fungal Infection Treatment
Superior Efficacy for Candidemia, Esophageal Candidiasis & Preventive Antifungal Therapy
Fast-Acting, Broad-Spectrum Coverage for Hospital & Outpatient Use
Micafungin for Injection 50mg by Biocon Pharma offers cutting-edge, hospital-grade treatment for life-threatening fungal infections. Formulated as a convenient, single-dose sterile powder vial, this echinocandin-class antifungal targets the most resilient fungal pathogens, including Candida and Aspergillus species. Trusted by infectious disease specialists and clinicians, this product is FDA-approved and conforms to the highest pharmaceutical manufacturing standards.
Unmatched Health Benefits
-
First-Line Therapy for Invasive Candidiasis & Candidemia: Highly effective for bloodstream Candida infections in both adult and pediatric patients.
-
Treatment of Esophageal Candidiasis: Delivers superior results for immunocompromised patients, including those with HIV/AIDS or cancer.
-
Proven Prophylaxis for Stem Cell Transplant Recipients: Provides essential antifungal prophylaxis in hematopoietic stem cell transplant (HSCT) patients at risk for invasive candidiasis.
-
Potent Echinocandin: Targeted therapeutic action against resistant Candida strains; an ideal alternative to azole and amphotericin-based therapies.
Clinical Uses & Indications
- Candidemia, Acute Disseminated Candidiasis, and Other Candida Infections
- Esophageal Candidiasis (including azole-resistant strains)
- Prophylaxis of Candida Infections in patients undergoing hematopoietic stem cell transplant
- Suitable for adults, children, and neonates when indicated by a healthcare provider
Product Specifications
- Strength: 50mg per vial (single-dose, preservative-free)
- Formulation: Sterile powder for reconstitution, IV use only
- Manufacturer: Biocon Pharma – Trusted global leader in antifungal medications
- NDC: 70377-0075-91
How It Works
Micafungin operates by inhibiting 1,3-beta-D-glucan synthesis, an essential component of the fungal cell wall, resulting in fungus death and clearance from the body. Its targeted action reduces drug-resistance and offers minimal risk of nephrotoxicity, making it safer than amphotericin B in critically ill patients.
Why Choose Micafungin Injection by Biocon Pharma?
- Fast onset of action for acute infections
- Highly effective where other antifungals fail
- Excellent safety and tolerability profile for a broad range of patients
- Minimal drug-drug interactions for complex, critically ill patients
- Backed by leading infectious disease specialists
- Meets cGMP and FDA quality guidelines
Order Micafungin Injection 50mg Vial by Biocon Pharma (NDC: 70377-0075-91) Today – Secure, Reliable, and Trusted by Hospitals and Pharmacists Nationwide!
For clinical use only. Consult your infectious disease specialist or healthcare provider for dosing and administration guidelines.
